225 related articles for article (PubMed ID: 16462498)
21. Time between the first day of chemotherapy and the last day of chest radiation is the most important predictor of survival in limited-disease small-cell lung cancer.
De Ruysscher D; Pijls-Johannesma M; Bentzen SM; Minken A; Wanders R; Lutgens L; Hochstenbag M; Boersma L; Wouters B; Lammering G; Vansteenkiste J; Lambin P
J Clin Oncol; 2006 Mar; 24(7):1057-63. PubMed ID: 16505424
[TBL] [Abstract][Full Text] [Related]
22. [Current perspectives in the management of small cell lung cancer].
Fujita J; Saijo N
Gan No Rinsho; 1985 Jan; 31(1):1-19. PubMed ID: 2984443
[TBL] [Abstract][Full Text] [Related]
23. Topotecan and cisplatin in combination with concurrent twice-daily chemoradiation in limited disease small cell lung cancer-a Danish Oncological Lung Cancer Group (DOLG) phase II trial.
Sorensen M; Lassen U; Palshof T; Jensen BB; Johansen J; Jensen PB; Langer SW
Lung Cancer; 2008 May; 60(2):252-8. PubMed ID: 18036701
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of curative and palliative radiotherapy efficacy in extensive stage small cell lung cancer.
Diniz G; Unlu I; Gokce T; Kilciksiz S; Gayaf M; Komurcuoglu B; Karadogan I; Aktas S; Akcay C
Saudi Med J; 2006 Jul; 27(7):992-6. PubMed ID: 16830017
[TBL] [Abstract][Full Text] [Related]
25. Post-chemotherapy gross tumor volume is predictive of survival in patients with stage III non-small cell lung cancer treated with combined modality therapy.
Stinchcombe TE; Morris DE; Moore DT; Bechtel JH; Halle JS; Mears A; Deschesne K; Rosenman JG; Socinski MA
Lung Cancer; 2006 Apr; 52(1):67-74. PubMed ID: 16499996
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the use of prophylactic cranial irradiation in small cell lung cancer.
Patel S; Macdonald OK; Suntharalingam M
Cancer; 2009 Feb; 115(4):842-50. PubMed ID: 19117355
[TBL] [Abstract][Full Text] [Related]
27. [Primary non-Hodgkin's lymphoma of the nasal cavity at early stage: long-term treatment outcomes and prognostic analyses of 108 cases].
He YF; Zhang YJ; Li YH; Lin TY; Xia YF; Lu TX; Huang HQ; Jiang WQ; Xian CG; He YJ; Guan ZZ
Ai Zheng; 2006 Dec; 25(12):1538-42. PubMed ID: 17166382
[TBL] [Abstract][Full Text] [Related]
28. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
29. Smoking affects treatment outcome in patients with advanced nonsmall cell lung cancer.
Tsao AS; Liu D; Lee JJ; Spitz M; Hong WK
Cancer; 2006 Jun; 106(11):2428-36. PubMed ID: 16634096
[TBL] [Abstract][Full Text] [Related]
30. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
[TBL] [Abstract][Full Text] [Related]
31. The influence of time of radio-chemotherapy and other therapeutic factors on treatment results in patients with limited disease small cell lung cancer.
Sas-Korczynska B; Sokolowski A; Korzeniowski S
Lung Cancer; 2013 Jan; 79(1):14-9. PubMed ID: 23153659
[TBL] [Abstract][Full Text] [Related]
32. Outcome and treatment in elderly patients with small cell lung cancer: a retrospective study.
Li J; Chen P; Dai CH; Li XQ; Bao QL
Geriatr Gerontol Int; 2009 Jun; 9(2):172-82. PubMed ID: 19740361
[TBL] [Abstract][Full Text] [Related]
33. Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.
Germain F; Wai ES; Berthelet E; Truong PT; Lesperance M
Am J Clin Oncol; 2008 Dec; 31(6):561-6. PubMed ID: 19060588
[TBL] [Abstract][Full Text] [Related]
34. Stage IB nonsmall cell lung cancers: are they all the same?
Jones DR; Daniel TM; Denlinger CE; Rundall BK; Smolkin ME; Wick MR
Ann Thorac Surg; 2006 Jun; 81(6):1958-62; discussion 1962. PubMed ID: 16731113
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of intensive follow-up after response in patients with small cell lung cancer.
Sugiyama T; Hirose T; Hosaka T; Kusumoto S; Nakashima M; Yamaoka T; Okuda K; Ohmori T; Adachi M
Lung Cancer; 2008 Feb; 59(2):255-61. PubMed ID: 17900754
[TBL] [Abstract][Full Text] [Related]
36. Surgery in the tri-modality treatment of small cell lung cancer. Stage-dependent survival.
Granetzny A; Boseila A; Wagner W; Krukemeyer G; Vogt U; Hecker E; Koch OM; Klinke F
Eur J Cardiothorac Surg; 2006 Aug; 30(2):212-6. PubMed ID: 16829087
[TBL] [Abstract][Full Text] [Related]
37. Second hand smoke exposure and survival in early-stage non-small-cell lung cancer patients.
Zhou W; Heist RS; Liu G; Asomaning K; Miller DP; Neuberg DS; Wain JC; Lynch TJ; Christiani DC
Clin Cancer Res; 2006 Dec; 12(23):7187-93. PubMed ID: 17145845
[TBL] [Abstract][Full Text] [Related]
38. [Treatment results of stage IA Hodgkin lymphoma: a report of 97 cases].
Tan WY; Hu DS; Zeng FY; Song QB; Hu S; Wei L; Zhou LQ
Ai Zheng; 2007 Dec; 26(12):1360-4. PubMed ID: 18076802
[TBL] [Abstract][Full Text] [Related]
39. Clinical manifestation and survival of patients with small-cell lung cancer.
Thammakumpee K; Juthong S; Viriyachaiyo V; Rittirak W; Tanomkiat W
J Med Assoc Thai; 2007 Jul; 90(7):1303-8. PubMed ID: 17710969
[TBL] [Abstract][Full Text] [Related]
40. Small cell carcinoma of the esophagus. Analysis of 14 cases and literature review.
Hosokawa A; Shimada Y; Matsumura Y; Yamada Y; Muro K; Hamaguchi T; Igaki H; Tachimori Y; Kato H; Shirao K
Hepatogastroenterology; 2005; 52(66):1738-41. PubMed ID: 16334769
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
